Definitive Contract IND17PC00405

Award Date 9/21/17
Potential Completion Date 2/20/21
Potential Value $1.5M
Contracting Federal Agency
Interior Business Center
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94117, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $220,661 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Scribe Biosciences, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a gene-encoded monoclonal antibody potency assay. Scribe Biosciences is a for-profit organization that provides research and development services related to biomedical engineering, microfluidics, genomics, and cell therapy to the...
This is a $3,007,557.97 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of new platform technologies for viral and therapeutic evolution assays under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a firm fixed price pricing type and a period of performance through November 2022. Autonomous Therapeutics has also...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
<p>This is a $149,998.88 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to De Novo DNA, a self-certified small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for &quot;HIGHLY SCALABLE MULTIPLEXED CRISPR APPLICATIONS USING ADVANCED PART TOOLBOXES AND CIRCUITS&quot; and has an ultimate completion date of October 7, 2018. The contract is designated as a Total Small Business set-aside.</p>
This is a $149,661.75 firm-fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer. The contract is for the development of a next-generation cell-free prototyping and biomanufacturing platform. Biodiscovery LLC, a subsidiary of the Japanese chemical company Daicel Corporation, specializes in custom molecular...
This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...
This is a firm fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Synvitrobio, Inc. (doing business as Tierra Biosciences), a minority-owned small business, in the amount of $149,999.91. The contract is for the development of &quot;rapid, reliable and repeatable platforms for cell-free prototyping&quot;, which supports DARPA's work in biosystems research and materials innovations for the military. Synvitrobio...
This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the &quot;REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES&quot; and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Bifrost Biosystems Inc., a for-profit manufacturing organization, for the development of &quot;Robust Operational Ultra-High Throughput Cell Lineage Tracking for Rapid Bioengineering and Pathogen Detection.&quot; The $1,496,610.00 Firm Fixed Price contract, set aside for small businesses, is intended to support DARPA's mission of technological superiority...
This is a $583,435.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Senti Biosciences, Inc. for a Biological Technologies Office study on programmable therapeutic cell circuit platforms. The contract has a completion date of January 31, 2018 and does not have a set-aside designation. As DARPA is the Defense Department's advanced research agency, this contract is likely part of their efforts to develop novel biotechnology capabilities for...

This is a $1,492,018.00 Firm Fixed Price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Scribe Biosciences, Inc., a small business, under the SBIR Program Phase II. The contract is for the development of "NEW PLATFORM TECHNOLOGIES FOR VIRAL AND THERAPEUTIC EVOLUTION ASSAYS." This contract is set aside for small businesses. Scribe Biosciences has previously received awards from the National Institutes of Health, National Science Foundation, and Department of Health and Human Services for research and development work related to infectious disease, cancer biology, genomics, and cell therapy, leveraging their proprietary microfluidics platform.

Generated 4/22/25, 9:43 AM